发明名称 |
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
摘要 |
Disclosed herein are therapeutic treatment protocols designed for the treatment of B cell lymphoma. These protocols are based upon therapeutic strategies which include the use of administration of immunologically active mouse/human chimeric anti-CD20 antibodies, radiolabeled anti-CD20 antibodies, and cooperative strategies comprising the use of chimeric anti-CD20 antibodies and radiolabeled anti-CD20 antibodies.
|
申请公布号 |
US2003147885(A1) |
申请公布日期 |
2003.08.07 |
申请号 |
US20020238681 |
申请日期 |
2002.09.11 |
申请人 |
IDEC PHARMACEUTICALS CORPORATION |
发明人 |
ANDERSON DARRELL R.;HANNA NABIL;LEONARD JOHN E.;NEWMAN ROLAND A.;REFF MITCHELL E.;RASTETTER WILLIAM H. |
分类号 |
A61K38/00;A61K47/48;C07K16/28;(IPC1-7):A61K39/395;A61K31/704;A61K31/66;A61K31/56;A61K31/474 |
主分类号 |
A61K38/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|